| Literature DB >> 31362999 |
Lihui Si1, Ruixin Lin2, Yan Jia1, Wenwen Jian1, Qing Yu1, Min Wang1, Shuli Yang3.
Abstract
Objectives: Lactobacillus bulgaricus may improve antioxidant capacity of black garlic in the prevention of gestational diabetes mellitus (GDM).Entities:
Keywords: Lactobacillus bulgaricus; antioxidant capacity; black garlic; gestational diabetes; oral glucose tolerance test
Year: 2019 PMID: 31362999 PMCID: PMC6689107 DOI: 10.1042/BSR20182254
Source DB: PubMed Journal: Biosci Rep ISSN: 0144-8463 Impact factor: 3.840
Figure 1The flowchart of the present study
The comparison of the main ingredients (g) of garlic (100 g) between two groups
| Before fermentation | After fermentation | |||
|---|---|---|---|---|
| BG | CG | BG | CG | |
| Water (g) | 63.8 | 62.3 | 53.7 | 52.5 |
| Total sugar | 7.2 | 7.4 | 28.5 | 26.1 |
| Reducing sugar | 0.3 | 0.3 | 9.7 | 6.4 |
| Polysaccharide | 6.9 | 7.1 | 18.8 | 19.7 |
| Protein | 5.2 | 5.5 | 7.4 | 6.9 |
| Lipid | 10.2 | 9.8 | 4.6 | 5.2 |
Figure 2FITR analysis of the functional groups in the polysaccharide of garlic
(A) The polysaccharide in BG group before fermentation. (B) The polysaccharide in CG group before fermentation. (C) The polysaccharide in BG group after fermentation. (D) The polysaccharide in CG group after fermentation. FITR; Fourier Transform infrared.
Figure 313C NMR analysis of the polysaccharide structure of garlic
(A) The polysaccharide in BG group before fermentation. (B) The polysaccharide in CG group before fermentation. (C) The polysaccharide in BG group after fermentation. (D) The polysaccharide in CG group after fermentation.
Figure 4The comparison of antioxidant capacity
(A) The reducing ability of polysaccharide among BG, CG and Vc groups before fermentation. (B) The reducing ability of polysaccharide among BG, CG and Vc groups after fermentation. (C) The T-AOC of polysaccharide among BG, CG and Vc groups before fermentation. (D) T-AOC of polysaccharide among BG, CG and Vc groups after fermentation. (E) The hydroxyl radical scavenging ability of polysaccharide among BG, CG and Vc groups before fermentation. (F) Hydroxyl radical scavenging ability of polysaccharide among BG, CG and Vc groups after fermentation. (G) ABTS free radical scavenging ability of polysaccharide among BG, CG and Vc groups before fermentation. (H) ABTS free radical scavenging ability of polysaccharide among BG, CG and Vc groups after fermentation. (I) DPPH free radical scavenging ability of polysaccharide among BG, CG and Vc groups before fermentation. (J) DPPH free radical scavenging ability of polysaccharide among BG, CG and Vc groups after fermentation. *P<0.05 vs. a control group.
Garlic volatile components in two groups
| Peaks | Compounds | Molecular formula | Molecular weight | Retention time (min) | Relative percent (%) | |
|---|---|---|---|---|---|---|
| CG | IG | |||||
| 1 | Allyl formate | C4H6O2 | 86.08 | 5.46 | 17.86 | 17.51 |
| 2 | Allyl sulfide | C6H1OS | 114.20 | 6.37 | 6.16 | 5.98 |
| 3 | N-octylpropyl sulfide | C4H10S | 90.18 | 9.33 | 0.17 | 0.18 |
| 4 | 2-methylpyrazine | C5H6N2 | 94.11 | 9.58 | 0.19 | 0.17 |
| 5 | Allyl methyl disulfide | C4H8S2 | 120.24 | 9.94 | 1.59 | 1.62 |
| 8 | Dimethyltrisulfide | C2H6S3 | 126.26 | 12.81 | 1.42 | 1.45 |
| 10 | A-angelica lactone | C5H6O2 | 98.10 | 14.47 | 0.61 | 0.59 |
| 12 | N,NW-methine triformamide | C4H7N3O3 | 145.12 | 15.06 | 0.72 | 0.70 |
| 13 | Diallyl disulfide | C8H12O4 | 172.18 | 15.46 | 25.41 | 25.04 |
| 14 | Furfural | C5H4O2 | 96.08 | 15.89 | 3.84 | 3.76 |
| 15 | 2-acetyl scent | C6H6O2 | 110.11 | 16.66 | 1.09 | 1.11 |
| 17 | Dimethyl malate | C6H10O5 | 162.14 | 17.26 | 1.61 | 1.52 |
| 22 | 5-methylfurfural | C6H6O2 | 110.11 | 18.71 | 2.30 | 2.37 |
| 23 | Diallyl trisulfide | C6H10S3 | 178.34 | 19.08 | 15.52 | 15.64 |
| 24 | 2,2-dimethyl-1,3-dithiane | C6H12S2 | 148.00 | 19.45 | 2.13 | 2.21 |
| 25 | Y-butyrolactone | C4H8O4 | 120.10 | 20.19 | 0.51 | 0.54 |
| 28 | Sterol | C5H6O2 | 98.10 | 21.15 | 0.97 | 0.92 |
| 30 | Y-caprolactone | C6H10O2 | 114.14 | 22.29 | 0.25 | 0.23 |
| 31 | 3-ethyl-3-hexanol | C8H18O | 130.23 | 22.88 | 0.19 | 0.18 |
| 33 | 2-Methoxycyclohexa-2,5-diene-1,4-dione | C7H6O3 | 138.12 | 23.17 | 2.42 | 2.39 |
| 35 | 146-trimethylnaphthalene | C13H14 | 170.25 | 24.59 | 2.12 | 2.14 |
| 36 | 1-methyl-4-piperidone-3 methyl decanoate | C8H13NO3 | 171.19 | 25.69 | 0.19 | 0.18 |
| 38 | 3-vinyl-3,4-dihydro-1,2-dithiocyclohexene | C6H8S2 | 144.26 | 25.93 | 0.39 | 0.36 |
| 42 | 1,3,5-trithiane | C3H6S3 | 138.27 | 28.49 | 0.19 | 0.20 |
| 52 | Methyl 14-methylpentadecanoate | C17H34O2 | 270.45 | 35.33 | 0.51 | 0.53 |
| 56 | 2-ethyltetrahydrothiophene | C6H12S | 116.22 | 38.92 | 4.81 | 4.84 |
| 62 | 4-methyl-1-carbaldehyde | C12H10O | 170.20 | 43.93 | 0.38 | 0.41 |
| 65 | Dibutyl phthalate | C16H22O4 | 278.34 | 44.99 | 0.93 | 0.95 |
Volatile components of black garlic between two groups
| Peaks | Compounds | Molecular formula | Molecular weight | Retention time (min) | Relative percent (%) | |
|---|---|---|---|---|---|---|
| IG | CG | |||||
| Acryl alcohol | C3H6O | 58.08 | 5.49 | 1.69 | 1.64 | |
| Allyl sulfide | C6H10S | 114.21 | 6.39 | 0.81 | 0.83 | |
| Ethanol | C2H5O6 | 46.07 | 7.13 | 2.98 | ||
| 2-methyl-1-butanol | C5H12O | 88.15 | 8.08 | 0.76 | ||
| Linalool | C10H18O | 154.25 | 9.21 | 2.03 | ||
| Allyl methyl disulfide | C4H8S2 | 120.24 | 9.97 | 4.54 | 4.73 | |
| 1,3-dithiane | C4H8S2 | 120.24 | 10.18 | 1.10 | 1.17 | |
| Citronellol | C10H20O | 156.27 | 11.38 | 0.95 | ||
| Dimethyltrisulfide | C2H6S4 | 126.26 | 12.96 | 0.69 | 0.71 | |
| Tetrahydro-2-hydrogen-1,4,6-oxodidiazepine ring | C5H10N2OS | 146.00 | 15.51 | 5.04 | 5.49 | |
| Diallyl disulfide | C8H12O4 | 172.18 | 16.11 | 15.08 | 17.53 | |
| 2-vinyl-1,3-dithiane | C6H10S2 | 146.00 | 16.27 | 8.90 | 8.81 | |
| NN-dimethylthiourea | C3H8N2S | 104.17 | 17.21 | 8.12 | 8.00 | |
| Ethylthiourea | C3H8N2OS | 120.17 | 17.73 | 0.05 | ||
| 2-ethyltetrahydrothiophene | C6H12S | 116.22 | 19.23 | 11.10 | 13.24 | |
| (methylthio)acetonitrile | C3H5NS | 87.14 | 19.32 | 1.32 | 1.39 | |
| H1-propenyl-1 cyano)-butane | C7HUS | 118.00 | 20.84 | 1.41 | 1.36 | |
| 5-methyl-1,2,4-triazole-3 sterol | C3H5N3S | 115.16 | 23.02 | 0.41 | 0.49 | |
| 3-vinyl-3,4-dihydro-1,2-dithiazide | C6H8S2 | 144.26 | 23.16 | 3.65 | 3.87 | |
| 2-ethylidene-1,3-dithiane | C6H10S2 | 146.00 | 23.88 | 0.14 | ||
| 3-vinyl-3,4-dihydro-1,2-dithiane | C6H8S2 | 144.26 | 24.79 | 16.69 | 17.56 | |
| 3,5-diethyl-1,2,4-tritetrahydrothiophene | C6H12S3 | 180.35 | 25.18 | 0.09 | 0.08 | |
| 135-trithiane | C3H6S3 | 138.27 | 25.72 | 0.16 | 0.18 | |
| (2 yl thio)-acetonitrile | C5H7NS | 113.00 | 25.78 | 0.12 | 0.11 | |
| Diallyl trisulfide | C6H10S3 | 178.34 | 25.99 | 2.87 | 2.95 | |
| 135-trithiane | C3H6S3 | 138.27 | 27.34 | 0.06 | ||
| 2-n-propylthiophene | C7H10S | 126.22 | 27.61 | 0.08 | 0.07 | |
| (2 yl thio)-acetonitrile | C5H7NS | 113.00 | 28.03 | 0.09 | 0.10 | |
| 135-trithiane | C3H6S3 | 138.27 | 29.89 | 0.15 | 0.14 | |
| 12-dithiocyclopentane | C3H6S2 | 106.21 | 30.74 | 0.08 | ||
| Ethyl acetate | C4H8O2 | 88.11 | 33.65 | 2.14 | ||
| Propyl propanoate | C6H12O2 | 116.16 | 35.72 | 0.19 | ||
| 2-thiophene | C4H3NO2S | 129.14 | 42.68 | 1.14 | 1.15 | |
Baseline characteristics of GDM patients between two groups
| Control group | t or χ2 | |||
|---|---|---|---|---|
| Age, year | 34.32 ± 6.47 | 34.51 ± 6.56 | −0.63 | 0.52 |
| Prepregnancy weight (kg) | 58.48 ± 7.36 | 58.17 ± 7.85 | 0.45 | 0.68 |
| Prepregnancy BMI (kg/m2) | 24.18 ± 3.91 | 23.72 ± 3.86 | 0.34 | 0.73 |
| Waist circumstance (cm) | 88.94 ± 9.38 | 90.53 ±10.12 | 0.45 | 0.52 |
| Gestational weeks | 12.14 ± 2.46 | 11.98 ± 2.27 | 0.67 | 0.39 |
| Walking | 51 (45.13) | 48 (42.48) | 0.74 | 0.95 |
| Jogging | 19 (16.81) | 22 (19.47) | ||
| Swimming | 8 (7.08) | 9 (7.96) | ||
| Sports | 10 (8.85) | 12 (10.62) | ||
| Yoga | 25 (22.12) | 22 (19.47) | ||
| Smoking | 26 (23.01) | 30 (26.55) | 0.38 | 0.54 |
| Drinking | 40 (35.4) | 34 (30.09) | 0.72 | 0.40 |
| FBG, mmol/l | 5.51±0.37 | 5.53 ± 0.42 | 0.15 | 0.87 |
| History of PCOS | 20 (17.7) | 24 (21.24) | 0.45 | 0.50 |
| Family history of diabetes | 34 (30.09) | 38 (33.63) | 0.33 | 0.57 |
| Large childbirth | 8 (7.08) | 12 (10.62) | 0.88 | 0.35 |
| Monthly income, RMB | 5378 ± 2654 | 5027 ± 2561 | 0.73 | 0.26 |
| Primary | 4 (3.54) | 6 (5.31) | 3.00 | 0.56 |
| High school | 21 (18.58) | 19 (16.81) | ||
| College | 25 (22.12) | 28 (24.78) | ||
| University | 52 (46.02) | 55 (48.67) | ||
| Masters/Ph.D. | 11(9.73) | 5(4.42) | ||
| Minority | 10 (8.85) | 14 (12.39) | 0.75 | 0.39 |
| Han people | 103 (91.15) | 99 (87.61) | ||
n=113 for each group.
The comparison of nutrition comparison between two groups
| Control group | ||||
|---|---|---|---|---|
| 1290 ± 351 | 1265 ± 363 | 1.64 | 0.67 | |
| 36.6 ± 13.8 | 37.1 ± 14.2 | 1.35 | 0.48 | |
| 37.8 ± 19.2 | 36.9 ± 19.5 | 1.56 | 0.35 | |
| 145.9 ± 58.8 | 152.9 ± 61.3 | 3.81 | 0.56 | |
| 431.6 ± 306.9 | 429.6 ± 321.1 | 0.26 | 0.84 | |
| 93.1 ± 56.7 | 92.8 ± 55.8 | 0.35 | 0.62 | |
| 213.4 ± 161.0 | 223.5 ± 156.4 | 1.49 | 0.27 | |
| 405.6 ± 341.7 | 412.5 ± 336.4 | 1.71 | 0.58 | |
| 17.8 ± 7.8 | 18.2 ± 7.5 | 0.64 | 0.91 | |
| 6.8 ± 2.1 | 6.9 ± 2.4 | 0.24 | 0.95 | |
| 1293 ± 356 | 1328 ± 362 | 0.17 | 0.89 | |
| 36.7 ± 13.8 | 35.5 ± 14.1 | 0.20 | 0.74 | |
| 36.4 ± 19.7 | 37.2 ± 20.3 | 0.83 | 0.60 | |
| 146.3 ± 58.4 | 142.5 ± 56.9 | 0.35 | 0.82 | |
| 411.8 ± 304.1 | 406.2 ± 313.6 | 0.54 | 0.67 | |
| 92.3 ± 56.2 | 93.7 ± 55.9 | 0.39 | 0.84 | |
| 211.5 ± 169.2 | 208.3 ± 172.6 | 0.28 | 0.73 | |
| 408.6 ± 341.8 | 412.5 ± 336.2 | 0.41 | 0.52 | |
| 18.5 ± 7.3 | 19.1 ± 8.0 | 0.76 | 0.40 | |
| 6.9 ± 2.9 | 7.1 ± 2.6 | 2.21 | 0.59 |
n=113 for each group.
The primary outcome of the number of abnormal OGTT values between two groups
| Abnormal OGTT | |||
|---|---|---|---|
| FBG | 1hBG | 2hBG | |
| 78 (69.03) | 45 (39.82) | 66 (58.41) | |
| 82 (72.57) | 40 (35.4) | 68 (60.18) | |
| 0.342 | 0.471 | 0.073 | |
| 0.558 | 0.492 | 0.787 | |
n=113 for each group.
The secondary outcome of the number of abnormal OGTT values between two groups
| Abnormal OGTT | |||
|---|---|---|---|
| FBG | 1hBG | 2hBG | |
| 89 (78.76) | 52 (46.02) | 76 (67.26) | |
| 65 (57.52) | 32 (28.32) | 48 (42.48) | |
| 11.740 | 7.579 | 14.009 | |
| 0.000† | 0.006* | 0.000† | |
n=113 for each group.
*P<0.01.
†P<0.001 vs. control group.
Pregnancy outcomes between two groups
| Gestational weeks | Weight gain (kg) | Cesarean section, | Labor induction, | Preeclampsia, | |
|---|---|---|---|---|---|
| 38.12 ± 1.82 | 16.47 ± 5.62 | 23 (20.35) | 0 (0.00) | 2 (1.77) | |
| 37.84 ± 0.94 | 13.85 ± 4.83 | 26 (23.01) | 0 (0.00) | 0 (0.00) | |
| 0.63 | 2.68 | 0.24 | 0.00 | 0.50 | |
| 0.28 | *0.03 | 0.68 | 1.00 | 0.48 |
n=113 for each group.
*P<0.05 vs. control group.
The incidence of perinatal complications between both groups
| Groups | Control group | χ2 | ||
|---|---|---|---|---|
| 0 (0.00) | 0 (0.00) | 0 | 1 | |
| 0 (0.00) | 0 (0.00) | 0 | 1 | |
| 0 (0.00) | 0 (0.00) | 0 | 1 | |
| 4 (3.54) | 2 (1.77) | 0.17 | 0.68 | |
| 16 (14.16) | 4 (3.54) | 7.90 | *0.01 | |
| 14 (12.39) | 2 (1.77) | 9.69 | *0.01 | |
| 10 (8.85) | 6 (5.31) | 1.08 | 0.30 | |
| 0 (0.00) | 0 (0.00) | 0 | 1 | |
| 10 (8.85) | 2 (1.77) | 5.63 | *0.02 |
n=113 for each group.
*P<0.05 vs. control group.
Comparison of plasma MDA, SOD, T-AOG and GSH-PX between two groups
| Parameters | Control group | |||
|---|---|---|---|---|
| MDA (nmol/ml) | 3.48 ±1.33 | 3.65 ±1.41 | 0.547 | 0. 261 |
| SOD (U/ml) | 59.57 ± 9.34 | 54.64 ±11.32 | 0.249 | 0. 091 |
| T-AOC (U/ml) | 6.01 ± 3.11 | 6.36 ± 2.55 | 0.197 | 0. 473 |
| GSH-PX (U/ml) | 162.39 ± 41.20 | 150.27 ± 42.03 | 0.348 | 0. 161 |
| MDA (nmol/ml) | 2.36 ±1.27 | 3.65 ± 1.42 | 8.398 | 0. 003* |
| SOD (U/ml) | 79.51 ± 8.53 | 62.89 ±15.49 | 4.562 | 0. 004* |
| T-AOC (U/ml) | 9.14 ± 3.27 | 6.38 ± 3.06 | 6.815 | 0. 000† |
| GSH-PX (U/ml) | 192.39 ± 52.61 | 136.43 ± 48.19 | 9.784 | 0. 002* |
*P<0.01.
†P<0.001 vs. control group.